Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at country level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1.1 Business trends
Chapter 3 US Direct-To-Consumer (DTC) Genetic Testing Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising public awareness regarding DTC genetic tests
3.2.1.2 Increasing demand for personalized DTC genetic services
3.2.1.3 Rising incidences of genetic disorders
3.2.2 Industry pitfalls & challenges
3.2.2.1 Defects in the DTC testing
3.2.2.2 Data privacy concerns associated with DTC genetic testing
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By technology
3.3.3 By distribution channel
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Future market trends
3.7 Regulatory landscape
3.8 Value chain analysis
3.9 Data privacy concerns
3.10 U.S. DTC genetic testing - pricing analysis, 2021
3.11 Reimbursement scenario
3.12 Porter’s analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive analysis of major market players
4.4 Competitive Positioning matrix
4.5 Company market share analysis, 2021
4.6 Strategy dashboard, 2021
Chapter 5 US Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type
5.1 Key segment trends
5.2 Carrier testing
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.3 Predictive testing
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.4 Ancestry & Relationship Testing
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.5 Nutrigenomics Testing
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.6 Skincare Testing
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
5.7 Others
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million & Units)
Chapter 6 US Direct-To-Consumer (DTC) Genetic Testing Market, By Technology
6.1 Key segment trends
6.2 Targeted analysis
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Single nucleotide polymorphism (SNP) chips
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Whole genome sequencing [WGS]
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 US Direct-To-Consumer (DTC) Genetic Testing Market, By Distribution Channel
7.1 Key segment trends
7.2 Online platforms
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Over-the-Counter
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Company Profiles
8.1 23andMe, Inc.
8.2 Ancestry
8.3 Counsyl
8.4 Easy DNA
8.5 HomeDNA
8.6 Family Tree DNA (Gene By Gene)
8.7 Full Genome Corporation Inc.
8.8 Helix OpCo LLC
8.9 Identigene, Inc.
8.10 Karmagenes SA
8.11 Living DNA Ltd.
8.12 MyHeritage Ltd.
8.13 Pathway genomics
8.14 Genesis Healthcare Co.
8.15 The SkinDNA Company Pty Ltd
8.16 Ambry Genetics
8.17 Blueprint Genetics Oy
8.18 DNA Genotek Inc.
8.19 Dante Lab
8.20 DNA Diagnostic Center
